Literature DB >> 10463477

Loss of heterozygosity in dysplasia and carcinoma of the gallbladder.

H J Chang1, S W Kim, Y T Kim, W H Kim.   

Abstract

The loss or inactivation of genes at specific chromosomal loci is one of the important mechanisms during the tumor development in humans. To investigate the role of genetic alterations in the carcinogenesis of gallbladder carcinoma, 32 carcinoma cases and 11 dysplasia cases of gallbladder were analyzed for loss of heterozygosity (LOH) and microsatellite instability (MI) on chromosomal regions 3p, 5q, 8p, 9p, 13q, 17p, and 18q with 17 microsatellite markers. Loss of one allele was identified on chromosomes 5q (55%) and 17p (40%) in dysplasias and on chromosomes 3p (52%), 5q (66%), 9p (52%), and 17p (58%) in carcinomas. LOH on chromosomes 13q and 18q was frequent only in advanced stage (III and IV) carcinomas (40% and 31%, respectively). LOH on chromosome 17p was correlated with intranuclear p53 accumulation. LOH on multiple chromosomes was more frequent in advanced carcinomas with metastasis than in cases without metastasis (P < .05). A widespread MI was observed in only one case of carcinoma. We conclude that LOH on 5q is an early change of carcinogenesis in gallbladder and that LOH on 3p and 9p is related to the progression of gallbladder carcinoma LOH on 13q and 18q is likely to be a late event. LOH on 17p occurs not only in dysplasia but also increases during the subsequent stages. Accumulation of LOH may be associated with carcinogenesis of the gallbladder, but the role of MI may not be significant.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10463477

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  14 in total

1.  Infrequent mismatch repair protein loss in gallbladder cancer patients in Japan.

Authors:  Hiroshi Yoshida; Kazuaki Shimada; Nobuyoshi Hiraoka
Journal:  Virchows Arch       Date:  2016-11-18       Impact factor: 4.064

2.  Genetic alterations and growth pattern in biliary duct carcinomas: loss of heterozygosity at chromosome 5q bears a close relation with polypoid growth.

Authors:  E Hidaka; A Yanagisawa; M Seki; T Setoguchi; Y Kato
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

3.  Expression of human telomerase catalytic protein in gallbladder carcinogenesis.

Authors:  B Luzar; M Poljak; A Cör; U Klopcic; V Ferlan-Marolt
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

4.  Microsatellite instability in gallbladder carcinoma.

Authors:  Andrea P Moy; Mohammad Shahid; Cristina R Ferrone; Darrell R Borger; Andrew X Zhu; David Ting; Vikram Deshpande
Journal:  Virchows Arch       Date:  2015-02-14       Impact factor: 4.064

5.  Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder.

Authors:  Gopal Nath; Anil K Gulati; Vijay K Shukla
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

6.  Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.

Authors:  Shih-Chang Chuang; King-Teh Lee; Kun-Bow Tsai; Pai-Ching Sheen; Eishi Nagai; Kazuhiro Mizumoto; Masao Tanaka
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

7.  Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas.

Authors:  Hee Jin Chang; Byong Chul Yoo; Sun Whe Kim; Byung Lan Lee; Woo Ho Kim
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

8.  Prognostic significance of race and tumor size in carcinosarcoma of gallbladder: a meta-analysis of 68 cases.

Authors:  Lanjing Zhang; Zheng Chen; Mariko Fukuma; Lisa Y Lee; Maoxin Wu
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

9.  Simultaneous gallbladder and bile duct cancers: revisiting the pathological possibilities.

Authors:  P J Shukla; S G Barreto; S V Shrikhande; M R Ramadwar; K K Deodhar; S Mehta; P Patil; K M Mohandas
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 10.  Molecular genetics and targeted therapeutics in biliary tract carcinoma.

Authors:  Eric I Marks; Nelson S Yee
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.